TNU-25707-93008
2 vaccinations
3 coded responses
7 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 240 / VA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Rhinorrhoea — Feeling: Poor · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workFree text: Coughing, running noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
-
2021-10-19
Survey response — 6 months, dose 2MedDRA: Urticaria chronic — Feeling: GoodFree text: I've been having chronic hives since May and it just occurred to me that they came on a month after my second doseMedDRA releases: 2024-11 · check-in free text available
-
2022-04-20
Survey response — 12 months, dose 2MedDRA: Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Developed chronic hives after 2nd shotMedDRA releases: 2024-11 · check-in free text available
-
2022-04-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-22
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Coughing, running nose
Release 10 — 6 months, dose 2
Symptoms: I've been having chronic hives since May and it just occurred to me that they came on a month after my second dose
Release 11 — 12 months, dose 2
Symptoms: Developed chronic hives after 2nd shot
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Urticaria | · | · | ✓ |
| SD | Urticaria chronic | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release